Genmab — Maj 2024
-
Hvis I har en LinkedIn profil, vil jeg anbefale at følge Claus Johansen. Han har mange gode indlæg om sundhedsaktier, deriblandt Genmab
-
https://investors.biontech.de/static-files/c8ca4858-2a59-45ab-bc43-6b1df6e3e784 biontech Q1 '24 presentation
-
Transactions in Connection with Share Buy-back Program https://www.proinvestor.com/investornyt/1155522/transactions-in-connection-with-share-buy-back-program
-
BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2024/05/06/biontech-se-bntx-q1-2024-earnings-call-transcript/
-
morningstar - Genmab’s results are tracking our expectations, and we maintain our fair value estimate of DKK 2,650 per share. https://www.morningstar.com/stocks/xcse/gmab/quote
-
Ja, det er p.t. lidt svært at se lyspunkterne i Genmab aktien. Lide
-
Lidt : Dead man walking...
-
Kort ugevideo: Speedsnak om Genmab, Gubra, Zealand Pharma, Bakkafrost, Avance Gas, BW-LPG m.fl https://www.proinvestor.com/boards/120315
-
Mim8 medwatch https://medwatch.dk/article17087988.ece
-
Lyder mere end godt - håber, at den kommer i land. Det vil være pragtfuldt

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
I would have expected ovarian cancer to be more logical